Gender risk of nonfatal stroke in type 2 diabetic patients differs depending on the type of treatment

Journal of Women's Health

Volumn 18, Issue 1, 2009, Pages 97-103

  Khalangot, Mykola ^a   Hu, Gang ^b,c,d   Tronko, Mykola ^a   Kravchenko, Victor ^a   Guryanov, Vitaliy ^e  

^a V P Komisarenko Institute of Endocrinology and Metabolism of the Ukraine Academy of Medical Sciences   (Ukraine)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e DONETSK MEDICAL UNIVERSITY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; INSULIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SEX RATIO; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; MEN'S HEALTH; MIDDLE AGED; ODDS RATIO; PREVALENCE; REGISTRIES; RISK FACTORS; SEX FACTORS; STROKE; TIME FACTORS; UKRAINE; WOMEN'S HEALTH;

EID: 58149383828     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0854     Document Type: Article

References (33)

1. Muller WA. Diabetes mellitus - Long time survival. J Insur Med 1998;30:17-27.
2. DECODE Study Group. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405.
3. Hu G, DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003;46:608-617.
4. Laakso M. Cardiovascular disease in type 2 diabetes: Challenge for treatment and prevention. J Intern Med 2001;249:225-235.
5. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
6. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996;27:63-68.
7. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke 1996;27:210-215.
8. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: A 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation 1998;98:1365-1371.
9. Hu G, Sarti C, Jousilahti P, et al. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005;36:2538-2543.
10. Hu G, Jousilahti P, Sarti C, Antikainen R, Tuomilehto J. The effect of diabetes and stroke at baseline and during follow-up on stroke mortality. Diabetologia 2006;49:2309-2316.
11. Haheim LL, Holme I, Hjermann I, Leren P. Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke 1993;24:1484-1489.
12. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke 1998;29:1341-1346.
13. Mulnier HE, Seaman HE, Raleigh VS, et al. Risk of stroke in people with type 2 diabetes in the UK: A study using the General Practice Research Database. Diabetologia 2006;49:2859-2865.
14. Mannucci E, Monami M, Masotti G, Marchionni N. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. Diabetes Metab Res Rev 2004;20:44-47.
15. Evans JM, Ogston SA, Emslie-Smith A, Morris AD. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: A comparison of patients treated with sulfonylureas and metformin. Diabetologia 2006;49:930-936.
16. Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006;29:254-258.
17. Ukraine Ministry of Health. [Main indicators of Endocrinological Care of Ukraine for 2004: Review.] Kiev: Ukraine Ministry of Health, 2005.
18. Khalangot M, Tronko M. Primary care diabetes in Ukraine. Primary Care Diabetes 2007;1:203-205.
19. Khalangot ND, Koka MA, Latypova GA, Bakhtiiarova AA. [Insulin edema in patients with diabetes mellitus and recent diabetic ketoacidosis (epidemiology and case reports)]. Lik Sprava 2004:39-43.
20. Tron'ko ND, Khalangot ND, Kravchenko VI, Kul'chinskaia Ia B, Gur'ianov VG, Mis'ko LA. [Incidence of proliferative retinopathy and sex-related differences in death rate among patients with diabetes mellitus and sight impairment treated with insulin (according to data from National Diabetic Registry)]. Lik Sprava 2004;29-32.
21. Vaiserman AM, Voitenko VP, Tronko ND, et al. [Role of seasonal factors in pre- and postnatal ontogenesis for etiology of type 1 diabetes mellitus.] Ontogenez 2006;37:279-285.
22. Vaiserman AM, Carstensen B, Voitenko VP, et al. Seasonality of birth in children and young adults (0-29 years) with type 1 diabetes in Ukraine. Diabetologia 2007;50:32-35.
23. Tronko M, Khalangot M, Kravcenko V, KulchinskaY, Vaiserman A. Gender distribution in Ukrainian adult insulintreated diabetics depending of age at diagnosis. Endocr Abstr 2006;11:P298.
24. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003;26:61-69.
25. Tang M, Chen Y, Krewski D. Gender-related differences in the association between socioeconomic status and self-reported diabetes. Int J Epidemiol 2003;32:381-385.
26. Rathmann W, Haastert B, Icks A, et al. Sex differences in the associations of socioeconomic status with undiagnosed diabetes mellitus and impaired glucose tolerance in the elderly population: the KORA Survey 2000. Eur J Public Health 2005;15:627-633.
27. Agardh EE, Ahlbom A, Andersson T, et al. Explanations of socioeconomic differences in excess risk of type 2 diabetes in Swedish men and women. Diabetes Care 2004;27:716-721.
28. Hegele RA, Eliasziw M, De Angelis M. Sex, diabetes, and stroke after carotid endarterectomy. Diabetes Care 2003;26:1641.
29. Bergh C, Carlsson B, Olsson JH, Selleskog U, Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 1993;59:323-331.
30. Stuart CA, Nagamani M. Insulin infusion acutely augments ovarian androgen production in normal women. Fertil Steril 1990;54:788-792.
31. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991;12:3-13.
32. Steinberg HO, Paradisi G, Cronin J, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000;101:2040-2046.
33. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006;49:1711-1721.